E&B Pharm Concilium supports pharmaceutical companies in accelerating their projects, from API development through regulatory submission, across all stages of the development lifecycle.

E&B Pharm Concilium brings together two senior executives from the pharmaceutical industry with more than 40 years of combined experience and highly complementary expertise. Emilie, an expert in regulatory affairs, clinical development and marketing authorisation strategy, and Babak, a specialist in chemical and process development from API to finished product, provide a complete and integrated understanding of drug development.

In an environment where navigating scientific and regulatory complexity has become a critical success factor, we offer far more than operational support: we provide a strategic, rigorous and structured view of your challenges. We work alongside R&D, regulatory affairs and executive teams to propose secure development pathways, accelerate decision‑making and maximise project value, from the initial design through to market access.

Our signature combines scientific excellence, regulatory insight and pragmatic decision‑making, with one clear goal: to turn complexity into a sustainable strategic advantage for our clients.